Abstract

493O - Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
340P Omega-3 fatty acids for cancer cachexia in advanced non-small cell lung cancer: A meta-analysis
A.V Chua ... M.D San Juan
Annals of Oncology | VOL. 31
A.V Chua, et. al.A.V Chua ... M.D San Juan
01 Nov 2020
Comparison and analysis among expression of CRP and tumor markers in advanced non-small cell lung cancer patients
X Ren ... W Dong
Journal of Clinical Oncology | VOL. 24
X Ren, et. al.X Ren ... W Dong
20 Jun 2006
MET Exon 14 Skipping Mutations: Essential Considerations for Current Management of Non–Small-Cell Lung Cancer
Kurtis D Davies ... Lauren L Ritterhouse
The Journal of Molecular Diagnostics | VOL. 24
Kurtis D Davies, et. al.Kurtis D Davies ... Lauren L Ritterhouse
10 May 2022
The multimodality therapy for patients with advanced non-small cell lung cancer (Stage IIIB and IV)
J Sun ... H Guo
Journal of Clinical Oncology | VOL. 23
J Sun, et. al.J Sun ... H Guo
01 Jun 2005
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: “ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe”, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
H Li ... E Song
Annals of Oncology | VOL. -
H Li, et. al.H Li ... E Song
01 May 2024
View more papers